ALLENA PHARMACEUTICALS INC (ALNA) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ALNA • US0181191075

0.075 USD
+0 (+3.16%)
At close: Sep 7, 2022
0.0665 USD
-0.01 (-11.33%)
After Hours: 9/7/2022, 8:15:20 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALNA. ALNA was compared to 524 industry peers in the Biotechnology industry. While ALNA seems to be doing ok healthwise, there are quite some concerns on its profitability. ALNA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ALNA had negative earnings in the past year.
ALNA Yearly Net Income VS EBIT VS OCF VS FCFALNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -10M -20M -30M -40M

1.2 Ratios

Industry RankSector Rank
ROA -243.13%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALNA Yearly ROA, ROE, ROICALNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -50 -100 -150 -200 -250

1.3 Margins

  • ALNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALNA Yearly Profit, Operating, Gross MarginsALNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021

More info and screens

4

2. Health

2.1 Basic Checks

  • ALNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALNA has been increased compared to 1 year ago.
  • ALNA has a worse debt/assets ratio than last year.
ALNA Yearly Shares OutstandingALNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M
ALNA Yearly Total Debt VS Total AssetsALNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

2.2 Solvency

  • ALNA has an Altman-Z score of -28.08. This is a bad value and indicates that ALNA is not financially healthy and even has some risk of bankruptcy.
  • ALNA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -28.08
ROIC/WACCN/A
WACC10.12%
ALNA Yearly LT Debt VS Equity VS FCFALNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that ALNA should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.58 indicates that ALNA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
ALNA Yearly Current Assets VS Current LiabilitesALNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

More info and screens

1

3. Growth

3.1 Past

  • ALNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 46.15%, which is quite impressive.
EPS 1Y (TTM)46.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 13.22% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y56.68%
EPS Next 2Y25.45%
EPS Next 3Y24.51%
EPS Next 5Y13.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALNA Yearly EPS VS EstimatesALNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALNA. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALNA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALNA Price Earnings VS Forward Price EarningsALNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.16
ALNA Per share dataALNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • ALNA's earnings are expected to grow with 24.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.45%
EPS Next 3Y24.51%

More info and screens

0

5. Dividend

5.1 Amount

  • ALNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLENA PHARMACEUTICALS INC / ALNA FAQ

What is the ChartMill fundamental rating of ALLENA PHARMACEUTICALS INC (ALNA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALNA.


What is the valuation status for ALNA stock?

ChartMill assigns a valuation rating of 1 / 10 to ALLENA PHARMACEUTICALS INC (ALNA). This can be considered as Overvalued.


What is the profitability of ALNA stock?

ALLENA PHARMACEUTICALS INC (ALNA) has a profitability rating of 0 / 10.


Can you provide the financial health for ALNA stock?

The financial health rating of ALLENA PHARMACEUTICALS INC (ALNA) is 1 / 10.